Society for Maternal-Fetal Medicine: Heightened inflammation susceptibility of the preterm fetus?
Preterm placenta may be more susceptible to maternal infection-induced placental cytokine response resulting in fetal inflammation, new research reveals.
The preterm placenta may be more susceptible to maternal infection-induced placental cytokine response resulting in fetal inflammation, reported researchers from UCLA Medical Center.
Julie Boles, MD, and colleagues used pregnant rats to determine that at day 16 of a 21-day term, placental explants exposed to 1 g/mL lipopolysaccharide (LPS) for 6 hours demonstrated a significant increase in IL-6 (5,072±624 vs 2,062±587 pg/mL/g tissue; P<.01), with a further increase after 12 hours (9,290±467 vs 2,313±268 pg/mL/g tissue; P<.01) compared with unexposed placentas.
In addition, the IL-6 cytokine response to 12-hour exposure to 1 g/mL LPS in 16-day placental explants was twice as high as that in 18-day placental explants.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
